[go: up one dir, main page]

AU2905597A - Anti-vaginitis composition for topical use comprising one or more anti-vaginitis medicaments and one or more local anaesthetics - Google Patents

Anti-vaginitis composition for topical use comprising one or more anti-vaginitis medicaments and one or more local anaesthetics

Info

Publication number
AU2905597A
AU2905597A AU29055/97A AU2905597A AU2905597A AU 2905597 A AU2905597 A AU 2905597A AU 29055/97 A AU29055/97 A AU 29055/97A AU 2905597 A AU2905597 A AU 2905597A AU 2905597 A AU2905597 A AU 2905597A
Authority
AU
Australia
Prior art keywords
vaginitis
composition
medicaments
topical use
local anaesthetics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29055/97A
Other languages
English (en)
Inventor
Koral Embil
Oswald Morton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Edko Trading and Representation Co Ltd
Original Assignee
Edko Trading and Representation Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10793879&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2905597(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Edko Trading and Representation Co Ltd filed Critical Edko Trading and Representation Co Ltd
Publication of AU2905597A publication Critical patent/AU2905597A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU29055/97A 1996-05-17 1997-05-16 Anti-vaginitis composition for topical use comprising one or more anti-vaginitis medicaments and one or more local anaesthetics Abandoned AU2905597A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9610359 1996-05-17
GBGB9610359.3A GB9610359D0 (en) 1996-05-17 1996-05-17 Pharmaceutical compositions
PCT/GB1997/001355 WO1997044032A1 (en) 1996-05-17 1997-05-16 Anti-vaginitis composition for topical use comprising one or more anti-vaginitis medicaments and one or more local anaesthetics

Publications (1)

Publication Number Publication Date
AU2905597A true AU2905597A (en) 1997-12-09

Family

ID=10793879

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29055/97A Abandoned AU2905597A (en) 1996-05-17 1997-05-16 Anti-vaginitis composition for topical use comprising one or more anti-vaginitis medicaments and one or more local anaesthetics

Country Status (12)

Country Link
EP (1) EP0910377A1 (id)
JP (1) JP2000513334A (id)
CN (1) CN1127338C (id)
AU (1) AU2905597A (id)
BR (1) BR9709316A (id)
GB (1) GB9610359D0 (id)
ID (1) ID16929A (id)
MY (1) MY127711A (id)
RU (1) RU2195281C2 (id)
TR (1) TR199802351T2 (id)
WO (1) WO1997044032A1 (id)
ZA (1) ZA974266B (id)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2777783A1 (fr) * 1998-04-24 1999-10-29 Innothera Lab Sa Association pharmaceutique d'imidazoles pour le traitement local des vulvo-vaginites infectieuses et des vaginoses
US5993836A (en) * 1998-04-28 1999-11-30 Castillo; James G. Topical anesthetic formulation
TWI232111B (en) * 1999-08-06 2005-05-11 Upjohn Co Intravaginal clindamycin ovule composition
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
WO2005027807A1 (en) 2003-09-19 2005-03-31 Drugtech Corporation Pharmaceutical delivery system
US8309103B2 (en) * 2004-01-22 2012-11-13 Alparis, S.A. De C.V. Association of fluconazole-tinidazole for the treatment of vaginal infections, its composition, preparation process and usage
GB0405406D0 (en) * 2004-03-10 2004-04-21 Edko Pazarlama Tanitim Ltd Sti Anti-vaginitis compositions
EP1909752A2 (en) * 2005-05-09 2008-04-16 Drugtech Corporation Modified-release pharmaceutical compositions
CN1291754C (zh) * 2005-07-12 2006-12-27 李赴朝 局麻药增效延时剂
JP2009522360A (ja) * 2006-01-05 2009-06-11 ドラッグテック コーポレイション 組成物およびその使用方法
AU2006332520A1 (en) * 2006-01-05 2007-07-12 Drugtech Corporation Drug delivery system for bioadhesion to a vulvovaginal surface
RU2605343C1 (ru) * 2015-11-30 2016-12-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Средство для лечения гнойно-воспалительных процессов мягких тканей и слизистых оболочек
RU2603490C1 (ru) * 2015-11-30 2016-11-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Средство для лечения гнойно-воспалительных процессов мягких тканей и слизистых оболочек
HRP20210762T1 (hr) 2016-07-08 2021-06-25 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Farmaceutski pripravak koji sadrži benzidamin
TR2023017366A1 (tr) * 2023-12-15 2025-06-23 Bilensoy Ibrahim Tamer Bi̇yoadezi̇f vaji̇nal farmasöti̇k si̇stemler

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8830405D0 (en) * 1988-12-30 1989-03-01 Embil Koral Pharmaceutical formulation
CA1337279C (en) * 1989-06-06 1995-10-10 Robert J. Borgman Intravaginal treatment of vaginal infections with buffered metronidazole compositions
RU2029548C1 (ru) * 1989-07-07 1995-02-27 Центр по химии лекарственных средств Антимикробное или радиосенсибилизирующее средство
GB9318641D0 (en) * 1993-09-08 1993-10-27 Edko Trading Representation Compositions

Also Published As

Publication number Publication date
WO1997044032A1 (en) 1997-11-27
ID16929A (id) 1997-11-20
BR9709316A (pt) 2000-05-02
JP2000513334A (ja) 2000-10-10
ZA974266B (en) 1998-11-16
MY127711A (en) 2006-12-29
RU2195281C2 (ru) 2002-12-27
CN1223581A (zh) 1999-07-21
CN1127338C (zh) 2003-11-12
TR199802351T2 (xx) 1999-03-22
EP0910377A1 (en) 1999-04-28
GB9610359D0 (en) 1996-07-24

Similar Documents

Publication Publication Date Title
AU2456097A (en) Topical barrier composition containing silicone and bentonite
HUP9903544A3 (en) Pharmaceutical composition with anaesthetic effect for local use
AU5136998A (en) Medicinal composition
AU1618697A (en) Novel compounds and pharmaceutical use thereof
HU0500549D0 (en) Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof
GB9508015D0 (en) Topical pharmaceutical compositions
AU6775098A (en) Topical moisturizing composition and method
AU4266596A (en) Composition and use
AU2905597A (en) Anti-vaginitis composition for topical use comprising one or more anti-vaginitis medicaments and one or more local anaesthetics
AU2630295A (en) 2-acylaminopropanol compound and medical composition
ZA975902B (en) Topical composition
HUP0001486A3 (en) Pharmaceutical composition for topical use cantaining nimesulide gel systems and process for preparation thereof
AU5161399A (en) N-benzocycloalkyl-amide derivatives and their use as medicaments
ZA949250B (en) Topical anti-inflammatory compositions containing piroxicam
AU3192295A (en) Substituted amine derivative and medicinal composition containing the same
IL140742A0 (en) Raloxifene and pharmaceutical composition comprising the same
IL130348A0 (en) Imidazopyridazines and medicaments containing the same
AU2310395A (en) Topical retinal-based composition
AU2100997A (en) Composition containing iso-flavonoids and lignans
ZA974126B (en) Topical composition
GB9606901D0 (en) Topical composition
AU7681498A (en) Pharmaceutical composition and use thereof
AU2550397A (en) Topical moisturizing composition and method
AU3982695A (en) Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines and their use as medicaments
AU691690B2 (en) Acrolein-releasing composition and use thereof